ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies
BKA Dayyeh, N Kumar, SA Edmundowicz… - Gastrointestinal …, 2015 - giejournal.org
The increasing global burden of obesity and its associated comorbidities has created an
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …
ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies
ABET Force, BKA Dayyeh, N Kumar… - Gastrointestinal …, 2015 - pubmed.ncbi.nlm.nih.gov
The increasing global burden of obesity and its associated comorbidities has created an
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …
Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology …
V Nobili, P Vajro, A Dezsofi, B Fischler… - Journal of pediatric …, 2015 - journals.lww.com
Morbid obesity is strongly associated with nonalcoholic fatty liver disease (NAFLD), which is
one of the most common causes of chronic liver disease worldwide. The present best …
one of the most common causes of chronic liver disease worldwide. The present best …
Intragastric balloon for management of severe obesity: a systematic review
E Yorke, NJ Switzer, A Reso, X Shi, C de Gara, D Birch… - Obesity surgery, 2016 - Springer
Older models of intragastric balloons (IGBs) had unacceptably high complication rates and
inconsequential weight loss. With FDA approval of newer models, we aimed to …
inconsequential weight loss. With FDA approval of newer models, we aimed to …
The impact of intragastric balloons on obesity-related co-morbidities: a systematic review and meta-analysis
VB Popov, A Ou, AR Schulman… - Official journal of the …, 2017 - journals.lww.com
Objectives Therapies less invasive than surgery and more effective than lifestyle and
pharmacotherapy are needed to contend with the obesity epidemic. Intragastric balloons …
pharmacotherapy are needed to contend with the obesity epidemic. Intragastric balloons …
Balancing risk and reward: a critical review of the intragastric balloon for weight loss
S Gaur, S Levy, L Mathus-Vliegen… - Gastrointestinal …, 2015 - giejournal.org
METHODS The MEDLINE database was searched for publications with the search terms
listed in Table 1. A total of 436 studies with abstracts available were found. A total of 281 …
listed in Table 1. A total of 436 studies with abstracts available were found. A total of 281 …
Efficacy and safety of intragastric balloon (IGB) in non-alcoholic fatty liver disease (NAFLD): a comprehensive review and meta-analysis
Intragastric balloon (IGB) therapy has shown efficacy in weight loss but its role in NAFLD
remains unknown. We conducted a systematic review and meta-analysis to evaluate the …
remains unknown. We conducted a systematic review and meta-analysis to evaluate the …
Intragastric balloon: a retrospective evaluation of 5874 patients on tolerance, complications, and efficacy in different degrees of overweight
RJ Fittipaldi-Fernandez, IJ Zotarelli-Filho, CF Diestel… - Obesity surgery, 2020 - Springer
Background Endoscopic methods, especially the intragastric balloon (IGB), have been
shown to be effective for the treatment of excess weight. This study aimed to assess the …
shown to be effective for the treatment of excess weight. This study aimed to assess the …
Effects of bariatric endoscopy on non-alcoholic fatty liver disease: A comprehensive systematic review and meta-analysis
M Ren, X Zhou, Y Zhang, F Mo, J Yang… - Frontiers in …, 2022 - frontiersin.org
Background and objective Endoscopic bariatric and metabolic therapies (EBMTs) are
emerging minimally invasive therapeutic options for obesity and its related complications …
emerging minimally invasive therapeutic options for obesity and its related complications …
Meta‐analysis: Impact of intragastric balloon therapy on NAFLD‐related parameters in patients with obesity
O Aoko, T Maharaj, F Boland… - Alimentary …, 2024 - Wiley Online Library
Background Non‐alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease affecting approximately 25% of adults in the western world. Intragastric balloon …
disease affecting approximately 25% of adults in the western world. Intragastric balloon …